NASDAQ
ACHC
Last Price
US $31.60
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Acadia Healthcare Company, Inc. cash flow to debt ratio of 4.97% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Acadia Healthcare Company, Inc.'s free cash flow has increased -21.54% from $-560.69M last year to $-439.91M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Acadia Healthcare Company, Inc.'s debt to equity ratio is 1.36, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Acadia Healthcare Company, Inc.'s debt has increased relative to shareholder equity from 0.68 last year to 1.36 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Acadia Healthcare Company, Inc. has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Acadia Healthcare Company, Inc.'s interest coverage ratio of 2.66 indicates that earnings with margin can cover interest payments on company debt
Financial risk - Profit margin growth.
Acadia Healthcare Company, Inc.'s profit margin has decreased (-505.20%) in the last year from 8.10% to -32.84%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Acadia Healthcare Company, Inc.'s short-term assets of $814.14M exceed its short-term liabilities of $525.19M
Decreasing performance - ROA.
Acadia Healthcare Company, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Acadia Healthcare Company, Inc.'s return on equity of -43.82%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Acadia Healthcare Company, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Acadia Healthcare Company, Inc. had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Acadia Healthcare Company, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Acadia Healthcare Company, Inc. has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Acadia Healthcare Company, Inc.'s yearly earnings has decreased -531.42% since last year from $255.61M to $-1.10G, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Acadia Healthcare Company, Inc.'s yearly revenue has increased 5.04% since last year from $3.15G to $3.31G, signaling increasing performance
Increasing performance - ROIC.
ROIC 7.69% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Acadia Healthcare Company, Inc.'s 3-year revenue CAGR of 8.27% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Acadia Healthcare Company, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Acadia Healthcare Company, Inc. had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Acadia Healthcare Company, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Acadia Healthcare Company, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Acadia Healthcare Company, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Acadia Healthcare Company, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Acadia Healthcare Company, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Acadia Healthcare Company, Inc. has a price-to-book ratio of 1.32x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Acadia Healthcare Company, Inc. has a price-to-sales ratio of 0.85x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-43.82%
Return on equity
ROIC: 7.69%
Valuation History
-2.5X
Price to Earnings
EV/EBITDA: -7.4X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $31.60
317.22%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.